Advarra Announces Appointments of Scott Hoffman as Chief Commercial Officer and Scott Uebele as Chief Operating Officer
Key leadership appointments highlight continued commitment to offering connected solutions across the clinical research ecosystem and providing best-in-class operational delivery to customers
SubjectWell Features Advarra Experts James Riddle and Luke Gelinas in White Paper
In a recent article, SubjectWell interviewed Advarra's James Riddle and Luke Gelinas, Compensation norms create inequity in clinical trials".
Updated Advarra Fee Schedules Now Available
TAdvarra’s updated fee schedules for IRB, IBC, DMC, and EAC are now available. The new fee schedules are effective January 1, 2023.
Winter Holiday Schedule 2022
Advarra’s offices will be closed Monday, December 26, through Monday, January 2, with the exception of our India office locations.
FDA Proposes Revised IRB Regulations, Including Required sIRB for Multisite Trials
The FDA released two proposed rules intended to partially harmonize its current regulations with the Revised Common Rule.
Advarra Achieves 1,000+ Site Milestone for its Gene Therapy Ready Network
Research involving gene therapy-based treatments can start more quickly with Advarra’s growing network of registered research sites.
Holiday Schedule – Labor Day
Advarra’s US and Canada offices will be closed all day Monday, September 5, 2022.
Advarra Launches Dedicated Support Services for Research Grant Applicants
Services will help ensure researchers submit a complete budget application that avoids post-award financial shortfalls
Advarra Launches Cloud-Based Secure Document Exchange to Accelerate Study Startup
Solution provides end-to-end integration and automated, seamless exchange of research documents between sites, sponsors, and CROs
Holiday Schedule – Independence Day (US) and Canada Day (CAN)
US offices will be closed/the IRB and IBC will not meet on July 5. Canada offices will be closed/the Canadian REB will not meet on July 1.
Advarra, Leading Provider of Life Sciences R&D Compliance and Technology Solutions, Secures Major Investment from Blackstone and CPP Investments
This investment will support next growth phase in Advarra’s journey to make clinical research safer, smarter, and faster
Advarra Releases Significant SiteIQ Product Enhancement to Increase Visibility into Site Capabilities
New insights into site capacity and safety resources improve site feasibility evaluations and decision-making for clinical research.